The largest database of trusted experimental protocols

Transit lt1

Manufactured by Takara Bio
Sourced in Japan

TransIT-LT1 is a non-liposomal transfection reagent developed by Takara Bio. It is designed for the efficient delivery of nucleic acids, such as plasmid DNA, into a variety of cell types. The core function of TransIT-LT1 is to facilitate the uptake of these molecules into the target cells, thereby enabling researchers to study gene expression, perform genetic manipulations, or conduct other related experiments.

Automatically generated - may contain errors

20 protocols using transit lt1

1

Spike-ACE2 Cell-Based Luciferase Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
To prepare spike-expressing cells, BHK-21 cells grown on 12-well plates were transfected with 500 ng of pCAGGS-spike, which encodes a codon-optimized spike gene, 600 ng of plasmid encoding T7 promoter-driven firefly luciferase, and 20 ng of pCAGGS-Renilla luciferase, by using TransIT-LT1 (TaKaRa). To prepare ACE2-expressing cells, VeroE6 or VeroE6/TMPRSS2 cells grown on 12-well plates were transfected with 500 ng of pCAGGS-human ACE2 and 800 ng of pCAGGS-T7 polymerase, by using TransIT-LT1 (TaKaRa). After 24 h, these cells were detached by using EDTA without trypsin, mixed 1:1, and reseeded into 24-well plates. After 24 h of co-culture, firefly and Renilla luciferase activities were measured with the Dual-Luciferase Reporter Assay System (Promega). The firefly luciferase activity was normalized to the Renilla luciferase activity.
+ Open protocol
+ Expand
2

Quantifying SARS-CoV-2 Spike-Mediated Cell Fusion

Check if the same lab product or an alternative is used in the 5 most similar protocols
This assay is based on a split-GFP system (pQCXIP-GFP1–10 and pQCXIP-GFP11) where GFP signals are produced upon cell fusion (Kodaka et al., 2015 (link)). The split GFP plasmids: pQCXIP-BSR-GFP1–10 and pQCXIP-GFP11 were a gift from Yutaka Hata (Addgene plasmid #68715, https://www.addgene.org/68715/ and #68716 https://www.addgene.org/68716/). Briefly, 200,000 Vero-TMPRSS2 cells were co-transfected with 500 ng pCAGGS- spike and 500 ng pQCXIP-GFP110 or pQCXIP-GFP11 using TransIT-LT1 (Takara; MIR2300). The next day, cells were detached, pooled and reseeded in black 96-well or 24-well plates (Greiner, M0562–32EA) at 25,000 and 200,000 total cells/well, respectively. After 24 h, cells were fixed with 4% paraformaldehyde in PBS for 10 min. To measure spike expression, cells were permeabilized with 0.1% Triton X-100 for 15 min and stained with primary antibody anti-S2 (Sino Biological, 40590-D001) and secondary Alexa-Fluor 594 goat anti-human antibody (Thermo Fisher, A-11014). DAPI was used to visualize the nucleus. Images of the whole wells were obtained and analyzed using the Celigo Image Cytometer (Nexcelom). GFP signals were normalized to spike expression and DAPI counts to represent fusion activity.
+ Open protocol
+ Expand
3

HA subunit cleavage and cell-cell fusion

Check if the same lab product or an alternative is used in the 5 most similar protocols
HeLa cells were transfected with a plasmid encoding HA derived from CA04 by using TransIT-LT1 (Takara Bio). At 24 h post-transfection, the cells were incubated for 15 min at 37 °C with BSA-MEM containing 5 μg/ml acetylated trypsin to cleave the HA0 into the HA1 and HA2 subunits, and then treated with a human mAb, S9-1-10/5-1, anti-HA stem CR9114, anti-HA head 4-6-19/6, or anti-B-HA 1429C6/3-3, at 20, 50, or 200 μg/ml for 1 h at 37 °C. Polykaryon formation was induced by exposing the cells to low-pH buffer (145 mM NaCl, 20 mM sodium citrate pH 5.5) for 5 min at room temperature. After the exposure, the low-pH buffer was replaced with MEM containing 10% FCS. After incubation for 90 min at 37 °C, the cells were fixed with 10% neutral buffered formalin, and then stained with Giemsa's solution.
+ Open protocol
+ Expand
4

Split-GFP Assay for Measuring Cell Fusion

Check if the same lab product or an alternative is used in the 5 most similar protocols
This assay is based on a split-GFP system (pQCXIP-GFP1-10 and pQCXIP-GFP11) where GFP signals are produced upon cell fusion (Kodaka et al., 2015 (link)). The split GFP plasmids: pQCXIP-BSR-GFP1-10 and pQCXIP-GFP11 were a gift from Yutaka Hata (Addgene plasmid #68715, https://www.addgene.org/68715/ and #68716 https://www.addgene.org/68716/). Briefly, 200,000 Vero-TMPRSS2 cells were co-transfected with 500 ng pCAGGS- spike and 500 ng pQCXIP-GFP1-10 or pQCXIP-GFP11 using TransIT-LT1 (Takara; MIR2300). The next day, cells were detached, pooled and reseeded in black 96-well or 24-well plates (Greiner, M0562-32EA) at 25,000 and 200,000 total cells/well, respectively. After 24 h, cells were fixed with 4% paraformaldehyde in PBS for 10 min. To measure spike expression, cells were permeabilized with 0.1% Triton X-100 for 15 min and stained with primary antibody anti-S2 (Sino Biological, 40590-D001) and secondary Alexa Fluor 594 goat anti-human antibody (Thermo Fisher, A-11014). DAPI was used to visualize the nucleus. Images of the whole wells were obtained and analyzed using the Celigo Image Cytometer (Nexcelom). GFP signals were normalized to spike expression and DAPI counts to represent fusion activity.
+ Open protocol
+ Expand
5

PPARγ Transcriptional Activity Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
HepG2-hNTCP-C4 cells were transfected with a reporter plasmid carrying a tandem repeat of the peroxisome proliferator-activated receptor (PPAR) response elements (PPREs) upstream of the firefly luciferase gene, together with expression plasmids encoding PPARγ and retinoid X receptor (RXR) α, using TransIT-LT1 (Takara Bio Inc.) according to the manufacturer's protocol. The cells were treated with the indicated compounds for 24 h and the luciferase activity was measured as described (Watashi et al., 2013 (link)) to assess the transcriptional activity of PPARγ.
+ Open protocol
+ Expand
6

Generation of Engineered Melanoma and Feeder Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
B16 mouse melanoma cells [35] (link) were transfected with the pcDNA3-mHEL plasmid by lipofection using Trans IT-LT1 (Takara), and cultured with G418 (2 mg/ml, Wako). Drug-resistant stable clones (B16-mHEL) were subsequently selected. B16 cells were retrovirally transduced with the pMX-mHEL-IRES-GFP, and then cloned by limiting dilution method to establish B16-mHEL-GFP cells. 40 LB, Balb/c 3T3 fibroblasts expressing exogenous CD40-ligand and BAFF, have been described previously [17] (link). 40 LB cells were transduced with the pMX-mHEL-IRES-GFP vector, and a single clone expressing mHEL and eGFP, termed 40 LB-mHEL, was selected by limiting dilution. To express FasL, 40 LB cells were first transduced with the pSIREN-RetroQ-shFas vector. The resultant Fas-knocked-down cells (40 LB-Fas) were then transduced with the pMX-FasL-IRES-hCD8 vector and a single clone expressing FasL and hCD8 (40 LB-FasL cells) was selected by limiting dilution. Finally, the 40 LB-FasL cells were transduced with the pMX-mHEL-IRES-GFP vector to obtain a single clone expressing mHEL and eGFP (40 LB-mHEL-FasL). B16 and 40 LB cells, and their derivatives, were maintained in D-MEM medium (high glucose; Wako) supplemented with 10% FBS, 100 units/ml penicillin, and 100 μg/ml streptomycin (GIBCO) in a humidified atmosphere at 37°C with 5% CO2.
+ Open protocol
+ Expand
7

SARS-CoV-2 Pseudovirus Infection Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
A pseudovirus assay was performed as previously described (29 (link)
– (link)
32 (link), 46 (link), 49 (link)
– (link)
57 (link)). Briefly, HIV-1-based, luciferase-expressing reporter viruses were pseudotyped with the S proteins of B236, B52, and their derivatives. HEK293T cells (3,000,000 cells) were cotransfected with 4 µg psPAX2-IN/HiBiT (58 (link)), 4 µg pWPI-Luc2 (58 (link)), and 2 µg plasmids expressing parental S or its derivatives using PEI Max (Polysciences, Cat# 24765-1) according to the manufacturer’s protocol. Two days post transfection, the culture supernatants were harvested, and the pseudoviruses were stored at −80°C until use. For pseudovirus infection, the amount of input virus was normalized to the HiBiT value measured by the Nano Glo HiBiT lytic detection system (Promega, Cat# N3040), which indicates the amount of p24 HIV-1 antigen. For target cells, the HOS-TMPRSS2 cells stably expressing a variety of Rhinolophus bat ACE2 (Fig. 1D) and the HEK293 cells transfected with the plasmids expressing R. pusillus and R. macrotis ACE2 and their derivatives with TransIT-LT1 (Takara, Cat# MIR2300) (Fig. 3B and D) were used. Two days post infection, the infected cells were lysed with a Bright-Glo Luciferase Assay System (Promega, Cat# E2620), and the luminescent signal was measured using a GloMax Explorer Multimode Microplate Reader (Promega).
+ Open protocol
+ Expand
8

Transient Transfection of HEK 293 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Transient transfection of HEK 293 cells was performed with TransIT-LT1 (Takara). For transfection, 14 μg of expression plasmid (3MST/pCI)9 (link) was mixed with 45 μL of TransIT-LT1 in 1.5 mL of Opti-MEM (Invitrogen) and then added to HEK 293 cells at 60–70% confluency in a 9 cm dish. Cells were harvested at 48 h post-transfection and washed with ice-cold PBS. After precipitation by centrifugation, cell pellets were resuspended in the ice-cold buffer and sonicated.
+ Open protocol
+ Expand
9

Construction and Characterization of Retroviral Vectors

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNA-modifying enzymes were purchased from Takara Bio (Otsu, Japan). Mammalian expression vectors pcDNA3.1(+) and pcDNA3.1/Hygro(+) encoding a neomycin-resistant gene (neor) and a hygromycin-resistant gene (hygr), respectively, were purchased from Invitrogen (Carlsbad, CA, USA). The cDNA of a red-emitting click beetle luciferase (CBR), murine RIP1 (mRIP1), and murine RIP3 (mRIP3) were obtained from Promega (Madison, WI, USA). A transfection reagent TransIT-LT1 was purchased from Takara Bio. An Escherichia coli strain, DH5α, was used as the bacterial host for construction of all vectors. The cDNAs encoding mRIP1, mRIP3, epitope-tagged CBR fragments, neor, and hygr were generated by polymerase chain reaction (PCR). All PCR fragments were sequenced using a genetic analyzer ABI310 (Applied Biosystems, Carlsbad, CA, USA). The cDNA fragments were subcloned into a retroviral vector pMX30 (link).
+ Open protocol
+ Expand
10

Induction and Inhibition of Procollagen Transport

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were grown in DMEM supplemented with 10% fetal bovine serum. RD human rhabdomyosarcoma cell line (ATCC; CCL-136) and the HT-1080 human osteosarcoma cell line (ATCC; CCL-121) were provided by Klaus Kuhn (Max Planck Institute, Germany). COS-7 and HeLa cells were purchased from JCRB (Osaka, Japan; JCRB9127 COS-7) and ATCC (CRM-CCL-2), respectively. All cells were confirmed free from mycoplasma infection. TransIT LT1 (Takara, Otsu, Japan) and RNAi-MAX (Invitrogen) were used for the transfection of plasmids and siRNA, respectively. To induce ER-to-Golgi transport of procollagen III and GFP-COL3A1, ascorbic acid phosphate (Wako, Osaka, Japan) was added to the medium at a final concentration of 136 µg/ml. Cycloheximide (Nacalai Tesque, Kyoto, Japan) was dissolved in phosphate-buffered saline and added to the medium at a final concentration of 100 µM. To inhibit the ER-to-Golgi transport by temperature shift, culture medium was replaced with MEM with Hanks’s balanced salt solution (Thermo Fisher Scientific) precooled at 15°C, and the cells were incubated in a normal incubator without CO2 supply. To restart ER-to-Golgi traffic, the medium was replaced with DMEM prewarmed at 37°C and returned to a CO2 incubator set at 37°C.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!